Affymax may consider filing for bankruptcy; cuts workforce by 75 pct

March 18 Mon Mar 18, 2013 5:36pm EDT

March 18 (Reuters) - Affymax Inc, which recalled its anemia drug Omontys in February, said it may consider selling itself or filing for bankruptcy among a range of strategic alternatives.

The company also said it fired its chief commercial officer as part of a plan to reduce about 75 percent of its workforce and reorganize its business to cut costs. ()

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.